Induction of CYP3As in HepG2 Cells by Several Drugs. Association between Induction of CYP3A4 and Expression of Glucocorticoid Receptor.-Reference-Cited by-同舟云学术

Induction of CYP3As in HepG2 Cells by Several Drugs. Association between Induction of CYP3A4 and Expression of Glucocorticoid Receptor.

Published:2003 Issue:4 Volume:26 Page:510-517
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Usui Tatsuhiro¹,Saitoh Yukiya¹,Komada Fusao¹

Affiliation:

1. Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Josai University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/26/4/26_4_510/_pdf

Reference51 articles.

1. 1) Present address: Division of Immunobiochemistry, Department of Clinical Dietitics and Human Nutrition, Faculty of Pharmaceutical Sciences, Josai University, Keyakidai, Sakado, Saitama 350–0295, Japan.

2. Substrates of human hepatic cytochrome P450 3A4

3. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature

4. Cytochrome P450 3A

5. Fetal hepatic drug elimination

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic disrupting chemicals in the intestine: the need for biologically relevant models;FEBS Open Bio;2024-09

2. Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes;British Journal of Clinical Pharmacology;2024-07-12

3. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes;Pharmaceutics;2024-05-30

4. 3D Bioprinting of Sugar Beet Pectin through Horseradish Peroxidase-Catalyzed Cross-Linking;ACS Applied Bio Materials;2024-05-02

5. Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism;Yonago Acta Medica;2024